PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $298,977 | -23.4% | 9,745 | 0.0% | 0.19% | -14.6% |
| Q2 2023 | $390,482 | -18.3% | 9,745 | -16.8% | 0.23% | -11.4% |
| Q1 2023 | $477,885 | +5.7% | 11,710 | 0.0% | 0.26% | +22.6% |
| Q4 2022 | $452,123 | -26.8% | 11,710 | +0.9% | 0.21% | -35.2% |
| Q3 2022 | $618,000 | -8.7% | 11,611 | 0.0% | 0.32% | -2.7% |
| Q2 2022 | $677,000 | -27.6% | 11,611 | -5.2% | 0.33% | -13.8% |
| Q1 2022 | $935,000 | -0.6% | 12,251 | -21.6% | 0.38% | +1.3% |
| Q4 2021 | $941,000 | +8.0% | 15,636 | +0.5% | 0.38% | -3.3% |
| Q3 2021 | $871,000 | -7.7% | 15,559 | 0.0% | 0.39% | -8.2% |
| Q2 2021 | $944,000 | -13.5% | 15,559 | 0.0% | 0.43% | +6.5% |
| Q1 2021 | $1,091,000 | +10.4% | 15,559 | -5.8% | 0.40% | +0.5% |
| Q4 2020 | $988,000 | -2.9% | 16,509 | -2.4% | 0.40% | -10.8% |
| Q3 2020 | $1,017,000 | +12.1% | 16,919 | -2.1% | 0.45% | +3.5% |
| Q2 2020 | $907,000 | +56.4% | 17,289 | 0.0% | 0.43% | +45.6% |
| Q1 2020 | $580,000 | +9.2% | 17,289 | +47.5% | 0.30% | +53.4% |
| Q4 2019 | $531,000 | +19.1% | 11,719 | 0.0% | 0.19% | +37.9% |
| Q3 2019 | $446,000 | -12.5% | 11,719 | 0.0% | 0.14% | -4.1% |
| Q2 2019 | $510,000 | – | 11,719 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |